Impact of Metastatic Pattern on Survival Following Pancreatectomy for Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Peritoneal metastases significantly worsen overall survival (OS) in pancreatic cancer patients post-surgery. This contrasts with other metastatic sites, highlighting a critical factor in pancreatic adenocarcinoma outcomes.
Area Of Science
- Oncology
- Gastroenterology
- Surgical Oncology
Background
- Pancreatic cancer incidence is rising, with over half of patients diagnosed with metastatic disease.
- Metastatic disease frequently develops after surgical resection for pancreatic adenocarcinoma.
- Understanding the impact of different metastatic patterns on patient outcomes is crucial.
Purpose Of The Study
- To investigate the impact of metastatic patterns on overall survival in pancreatic cancer patients.
- To identify factors associated with specific metastatic patterns.
- To compare outcomes based on the site of metastasis after treatment.
Main Methods
- Retrospective chart review of pancreatic adenocarcinoma patients (2012-2023).
- Identification of patients with initial or developed metastatic disease.
- Univariate analysis and Kaplan-Meier survival curves to assess metastatic site impact.
Main Results
- Out of 330 patients, 41.8% presented with initial metastatic disease.
- Median overall survival (OS) for patients with metastases was 6 months.
- Patients developing peritoneal metastasis after surgery had significantly worse OS (5.4 months) than those with other metastases (9.2 months).
Conclusions
- Peritoneal metastasis following pancreatic cancer surgery is linked to poorer overall survival.
- Metastatic site significantly influences outcomes in pancreatic cancer.
- This finding underscores the importance of considering metastatic patterns in treatment strategies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...